New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

FDA Lets Pharmacists Prescribe COVID-19 Pill

An FDA revision to the emergency use authorization of Paxlovid allows pharmacists to prescribe the antiviral drug.

Gettyimages 1238868405 Slide C8357f0ce7718bb9c7b7da3a9e823c8c860d4f86

According to a recent Reuter’s article, pharmacists can now prescribe Pfizer’s COVID-19 pill to help improve access to the treatment. Previously, Paxlovid could only be prescribed by physicians and COVID test sites for people at risk of complications from the virus. The FDA has amended the emergency use authorization to make it prescribable by state-licensed pharmacists.

The agency instructs people who have tested positive for COVID-19 to bring their health records to pharmacists to ensure no kidney or liver issues, which could affect doses. Because the pill must be taken within five days of symptoms commencing, allowing pharmacists to prescribe it will expand accessibility to timely treatment.  

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts